Free Research Reports on CLRX, GALE and JCP Issued by the Bedford Report

NEW YORK, NY -- (Marketwired) -- 04/10/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

CollabRx Inc. (NASDAQ: CLRX) shares spiked sharply in early Tuesday trading before settling to close at $3.34 a share, a decrease of 2.91 percent. The company announced that it has entered into a partnership with Sengenics "to provide turn-key diagnostic decision making solutions for Asian and global markets."

Find out more about CollabRx including full access to the free equity report at: www.BedfordReport.com/CLRX

Galena Biopharma Inc. (NASDAQ: GALE) shares spiked 4.57 percent on volume of over 3.5 million shares traded Tuesday. The company has recently reached an agreement with Sweden-based Orexo AB to acquire Abstral (fentanyl) Sublingual Tablets, a treatment approved for cancer pain, for sale and distribution in the U.S.

Find out more about Galena Biopharma including full access to the free equity report at: www.BedfordReport.com/GALE

J.C. Penney Company, Inc. (NYSE: JCP) shares declined 12.22 percent on volume of nearly 90 million shares traded Tuesday to close at $13.93 a share. The company announced that Myron E. Ullman, III has rejoined the company as Chief Executive Officer, effective immediately. Ron Johnson has stepped down and will be leaving the company.

Find out more about J.C. Penney including full access to the free equity report at: www.BedfordReport.com/JCP

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.